Header Logo

Connection

LUCAS WONG to Depsipeptides

Back to Details
This is a "connection" page, showing publications LUCAS WONG has written about Depsipeptides.
LUCAS WONG
Connection Strength
0.080
Depsipeptides
  1. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Invest New Drugs. 2009 Oct; 27(5):469-75.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.